Aortic stenosis is the most common valvular disease worldwide. With transcatheter aortic
valve replacement (TAVR) being increasingly expanded to lower-risk populations, several …

Aims: The impact of the severity of coronary artery disease (CAD) and percutaneous
coronary interventions (PCI) on outcomes after transcatheter aortic valve implantation (TAVI) …

Aims To evaluate whether liver disease is associated with increased mortality after
transcatheter aortic valve implantation (TAVI) and whether TAVI is associated with …

To evaluate the clinical application effect of spiral computed tomography (CT) three‐
dimensional (3D) reconstruction based on artificial intelligence in transcatheter aortic valve …

Recently, two randomized trials, the PARTNER 3 and the Evolut Low Risk Trial,
independently demonstrated that transcatheter aortic valve replacement (TAVR) is non …

Aims We compared strategies in the treatment of decompensated severe aortic stenosis.
The hypothesis was that undertaking urgent or emergency transcatheter aortic valve …

Transcatheter aortic valve implantation (TAVI) is a less invasive alternative to surgical
implantation and its implementation is progressively increasing worldwide. We routinely …

The objective of this study was to compare oxidative stress indices in 24 patients (mean±SD
age 71±13 years) undergoing surgical aortic valve replacement (SAVR) versus …

Objective Even in high‐risk trials pertaining to transcatheter aortic valve replacement
(TAVR), patients with end‐stage liver disease (ESLD) have been under‐represented. We …

Introduction This study aimed to compare the vascular enhancement and radiation dose in
preoperative transcatheter aortic valve implantation (TAVI) computed tomography (CT) with …